ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Pain Medicine

Top Pain Medicine Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARIA CABODEVILLA-CONN MD

Pain Medicine

728

$65.5K

139
54 are 65+

65%
patients receiving schedule two controlled substances

Avg: 30%

31%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $100

DANIEL KOHANE M.D.

Pain Medicine

638

$47.8K

123
71 are 65+

59%
patients receiving schedule two controlled substances

Avg: 30%

25%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $100

ELIZABETH CHANDLER MD

Pain Medicine

774

$63.4K

194
49 are 65+

71%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$82
Average prescription price

Avg: $100

TAHIR QAZI MD

Pain Medicine

974

$111K

68
38 are 65+

41%
patients receiving schedule two controlled substances

Avg: 30%

62%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $100

VIDYASAGAR MOKUREDDY M.D.

Pain Medicine

762

$41.4K

264
123 are 65+

60%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $100

ADAKU NWACHUKU D.O.

Pain Medicine

569

$44K

162
51 are 65+

67%
patients receiving schedule two controlled substances

Avg: 30%

15%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $100

JOHN VLATTAS MD

Pain Medicine

641

$40K

103
46 are 65+

35%
patients receiving schedule two controlled substances

Avg: 30%

50%
patients receiving schedule three controlled substances

Avg: 18%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

STEPHEN WADE M.D.

Pain Medicine

1,645

$154K

206
68 are 65+

45%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $100

KEVIN WEINER M.D.

Pain Medicine

1,704

$177K

149
47 are 65+

67%
patients receiving schedule two controlled substances

Avg: 30%

12%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 24%

$104
Average prescription price

Avg: $100

NEIL PATEL MD

Pain Medicine

993

$111K

246
150 are 65+

54%
patients receiving schedule two controlled substances

Avg: 30%

27%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$112
Average prescription price

Avg: $100

VIJAY SIDHWANI D.O.

Pain Medicine

945

$197K

91
47 are 65+

53%
patients receiving schedule two controlled substances

Avg: 30%

15%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$208
Average prescription price

Avg: $100

JOSEPH BAX D.O.

Pain Medicine

546

$34.1K

131
78 are 65+

57%
patients receiving schedule two controlled substances

Avg: 30%

24%
patients receiving schedule three controlled substances

Avg: 18%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

PAUL SORELL M.D.

Pain Medicine

1,616

$280K

69
17 are 65+

65%
patients receiving schedule two controlled substances

Avg: 30%

22%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 24%

$173
Average prescription price

Avg: $100

QUENTIN PHUNG MD

Pain Medicine

598

$24.4K

107
48 are 65+

21%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $100

DENNY BATTISTA D.O.

Pain Medicine

755

$111K

172
94 are 65+

56%
patients receiving schedule two controlled substances

Avg: 30%

13%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

37%
prescriptions for brand name drugs

Avg: 24%

$148
Average prescription price

Avg: $100

REUBEN INGBER

Pain Medicine

513

$93.5K

85
63 are 65+

41%
patients receiving schedule two controlled substances

Avg: 30%

18%
patients receiving schedule three controlled substances

Avg: 18%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$182
Average prescription price

Avg: $100

CY BLANCO M.D.

Pain Medicine

522

$62.1K

138
82 are 65+

47%
patients receiving schedule two controlled substances

Avg: 30%

24%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$119
Average prescription price

Avg: $100

JONATHAN MOLDOVER M.D.

Pain Medicine

2,773

$592K

305
178 are 65+

53%
patients receiving schedule two controlled substances

Avg: 30%

14%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$213
Average prescription price

Avg: $100

DANIEL PERRI MD

Pain Medicine

1,277

$118K

140
86 are 65+

43%
patients receiving schedule two controlled substances

Avg: 30%

28%
patients receiving schedule three controlled substances

Avg: 18%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$92
Average prescription price

Avg: $100

CHARLES BUTTACI D.O.

Pain Medicine

867

$46.7K

272
200 are 65+

16%
patients receiving schedule two controlled substances

Avg: 30%

50%
patients receiving schedule three controlled substances

Avg: 18%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $100

SAJID KHAN M.D.

Pain Medicine

576

$39.9K

158
83 are 65+

42%
patients receiving schedule two controlled substances

Avg: 30%

37%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $100

XIAO FANG M.D.

Pain Medicine

1,065

$109K

103
25 are 65+

41%
patients receiving schedule two controlled substances

Avg: 30%

30%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$102
Average prescription price

Avg: $100

GERMAINE ROWE MD

Pain Medicine

666

$62K

269
113 are 65+

52%
patients receiving schedule two controlled substances

Avg: 30%

13%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$93
Average prescription price

Avg: $100

STEVEN WEINSTEIN M.D.

Pain Medicine

506

$31.2K

110
69 are 65+

25%
patients receiving schedule two controlled substances

Avg: 30%

35%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $100

ARASH YADEGAR M.D.

Pain Medicine

383

$26.4K

145
102 are 65+

29%
patients receiving schedule two controlled substances

Avg: 30%

23%
patients receiving schedule three controlled substances

Avg: 18%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$69
Average prescription price

Avg: $100

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank